- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2523-3106
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum defensin levels in patients with systemic sclerosis ; volume:60 ; number:1 ; day:22 ; month:12 ; year:2020 ; pages:1-5 ; date:12.2020
Advances in rheumatology ; 60, Heft 1 (22.12.2020), 1-5, 12.2020
- Urheber
-
Gedik, Tugce Emiroglu
Kucuk, Hamit
Goker, Berna
Haznedaroglu, Seminur
Pasaoglu, Hatice
Varan, Ozkan
Ozturk, Mehmet Akif
Pasaoglu, Ozge Tugce
Tufan, Abdurrahman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42358-020-00156-2
- URN
-
urn:nbn:de:101:1-2021013008391202647290
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gedik, Tugce Emiroglu
- Kucuk, Hamit
- Goker, Berna
- Haznedaroglu, Seminur
- Pasaoglu, Hatice
- Varan, Ozkan
- Ozturk, Mehmet Akif
- Pasaoglu, Ozge Tugce
- Tufan, Abdurrahman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
Increased serum levels of fractalkine and mobilisation of CD34+CD45− endothelial progenitor cells in systemic sclerosis
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
![Host defensin (human β-defensin [beta-defensin] 3) regulation by Helicobacter pylori](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Host defensin (human β-defensin [beta-defensin] 3) regulation by Helicobacter pylori
Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
Increased serum levels of fractalkine and mobilisation of CD34+CD45− endothelial progenitor cells in systemic sclerosis
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Host defensin (human β-defensin [beta-defensin] 3) regulation by Helicobacter pylori
Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
Increased serum levels of fractalkine and mobilisation of CD34+CD45− endothelial progenitor cells in systemic sclerosis
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease